
Pharmacoeconomic aspects of the targeted drugs use in psoriatic arthritis in context of the Russian healthcare system
Author(s) -
O. Ivakhnenko,
Т. В. Коротаева,
Т. В. Дубинина,
А. М. Лила
Publication year - 2022
Publication title -
sovremennaâ revmatologiâ
Language(s) - English
Resource type - Journals
eISSN - 2310-158X
pISSN - 1996-7012
DOI - 10.14412/1996-7012-2022-5-28-37
Subject(s) - certolizumab pegol , medicine , golimumab , adalimumab , tofacitinib , psoriatic arthritis , etanercept , secukinumab , context (archaeology) , ustekinumab , clinical trial , rheumatoid arthritis , paleontology , biology